Magnetic resonance imaging of the prostate

Area of Science:

• Radiology
• Oncology
• Medical Imaging

Background:

• Magnetic resonance imaging (MRI) demonstrates higher accuracy than other modalities for evaluating prostate malignancies and benign lesions.
• Despite its accuracy, MRI's cost and limited availability restrict its routine use, positioning it as a secondary problem-solving tool after CT or ultrasound.

Purpose of the Study:

• To evaluate the role and effectiveness of magnetic resonance imaging in prostate cancer diagnosis, staging, and treatment planning.
• To explore the potential of advanced MRI techniques, such as magnetic resonance spectroscopy, in improving prostate cancer evaluation.

Main Methods:

• Review of published data on the accuracy and utility of MRI in prostate cancer.
• Analysis of MRI's role in pre-surgical staging, radiotherapy planning, and tumor delineation.
• Inclusion of magnetic resonance spectroscopy (MRS) as a complementary technique.

Main Results:

• MRI is more accurate than other imaging methods for prostate lesions.
• Routine MRI for pre-surgical staging of prostate cancer is not supported by current data.
• MRI is beneficial for radiotherapy planning and improves tumor detection and extent delineation when combined with MRS.

Conclusions:

• Magnetic resonance imaging is a highly accurate tool for prostate cancer evaluation, particularly when used selectively.
• Its role is primarily as a problem-solver and in radiotherapy planning, with advanced techniques like MRS enhancing diagnostic capabilities.
• Future advancements in MRI technology promise further significant impacts on prostate imaging.